Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

You are pointing out all these issues due to the OTC. There is no analyst coverage (there wouldn’t be at this level of on NASDAQ either as they need to be much larger), there are no large funds buying in, etc. Quit blaming conspiracy theories for what is right there. Just because assets = market cap or revs are close to market cap doesn’t automatically mean the company must be valued as such. Elite has significant risks still (less today than in past) and discounts are factored in.

Bottom line is that you are blaming retail shareholders for not valuing the company appropriately when management keeps us on the OTC. On many days the volume is so light, which means there is no demand, the story is not out there and no one cares at this point other than retail shareholders.

Will things change? I certainly hope so, but with only a couple of tiny ANDAs in FDA review stage I’m skeptical of much movement. Oxy ANDA would be great, but who knows when we’d be able to actually launch even if approved. Not anytime soon. I’d like to see the BE study for the needle movers with an attached filing date . This can help get more RETAIL shareholders excited, but that’s it, unless the company is for sale. We’ll
Also continue the same slow slog until we move to an exchange.